Andersson BS - Search Results

1

Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-day mortality.

Kashyap A, Wingard J, Cagnoni P, Roy J, Tarantolo S, Hu W, Blume K, Niland J, Palmer JM, Vaughan W, Fernandez H, Champlin R, Forman S, Andersson BS. Kashyap A, et al. Among authors: andersson bs. Biol Blood Marrow Transplant. 2002;8(9):493-500. doi: 10.1053/bbmt.2002.v8.pm12374454. Biol Blood Marrow Transplant. 2002. PMID: 12374454 Free article. Clinical Trial.

2

High-dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remissions, but a high rate of regimen-related toxicity.

van Besien K, Tabocoff J, Rodriguez M, Andersson B, Mehra R, Przepiorka D, Dimopoulos M, Giralt S, Suki S, Khouri I, et al. van Besien K, et al. Bone Marrow Transplant. 1995 Apr;15(4):549-55. Bone Marrow Transplant. 1995. PMID: 7655380

3

Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts.

Körbling M, Przepiorka D, Huh YO, Engel H, van Besien K, Giralt S, Andersson B, Kleine HD, Seong D, Deisseroth AB, et al. Körbling M, et al. Blood. 1995 Mar 15;85(6):1659-65. Blood. 1995. PMID: 7888684 Free article.

4

High doses of cyclophosphamide, etoposide and total body irradiation followed by autologous stem cell transplantation in the management of patients with chronic myelogenous leukemia.

Kantarjian HM, Talpaz M, Andersson B, Khouri I, Giralt S, Rios MB, Champlin R, Hester J, Deisseroth AB. Kantarjian HM, et al. Bone Marrow Transplant. 1994 Jul;14(1):57-61. Bone Marrow Transplant. 1994. PMID: 7951120 Clinical Trial.

5

A phase I-II study of high-dose thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic marrow transplantation.

Przepiorka D, Ippoliti C, Giralt S, van Beisen K, Mehra R, Deisseroth AB, Andersson B, Luna M, Cork A, Lee M, et al. Przepiorka D, et al. Bone Marrow Transplant. 1994 Sep;14(3):449-53. Bone Marrow Transplant. 1994. PMID: 7994271 Clinical Trial.

6

Low-dose non-glycosylated rhGM-CSF is effective for the treatment of delayed hematopoietic recovery after autologous marrow or peripheral blood stem cell transplantation.

Ippoliti C, Przepiorka D, Giralt S, Andersson BS, Wallerstein RO, Gutterman J, Deisseroth AB, Champlin RE. Ippoliti C, et al. Among authors: andersson bs. Bone Marrow Transplant. 1993 Jan;11(1):55-9. Bone Marrow Transplant. 1993. PMID: 8094309

7

Thiotepa, busulfan, and cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myeloma.

Dimopoulos MA, Alexanian R, Przepiorka D, Hester J, Andersson B, Giralt S, Mehra R, van Besien K, Delasalle KB, Reading C, et al. Dimopoulos MA, et al. Blood. 1993 Oct 15;82(8):2324-8. Blood. 1993. PMID: 8104539 Free article. Clinical Trial.

8

Use of two retroviral markers to test relative contribution of marrow and peripheral blood autologous cells to recovery after preparative therapy. The University of Texas M.D. Anderson Cancer Center. Division of Medicine.

Deisseroth AB, Kantarjian H, Talpaz M, Champlin R, Reading C, Andersson B, Claxton D. Deisseroth AB, et al. Hum Gene Ther. 1993 Feb;4(1):71-85. doi: 10.1089/hum.1993.4.1-71. Hum Gene Ther. 1993. PMID: 8461383 Clinical Trial. No abstract available.

9

Effect of prior interferon alfa therapy on the outcome of allogeneic bone marrow transplantation for chronic myelogenous leukemia.

Giralt SA, Kantarjian HM, Talpaz M, Rios MB, Del Giglio A, Andersson BS, Przepiorka D, Deisseroth AB, Champlin RE. Giralt SA, et al. Among authors: andersson bs. J Clin Oncol. 1993 Jun;11(6):1055-61. doi: 10.1200/JCO.1993.11.6.1055. J Clin Oncol. 1993. PMID: 8501491

10

Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology.

van Besien KW, Mehra RC, Giralt SA, Kantarjian HM, Pugh WC, Khouri IF, Moon Y, Williams P, Andersson BS, Przepiorka D, McCarthy PL, Gajewski JL, Deisseroth AB, Cabanillas FF, Champlin R. van Besien KW, et al. Among authors: andersson bs. Am J Med. 1996 Mar;100(3):299-307. doi: 10.1016/S0002-9343(97)89488-0. Am J Med. 1996. PMID: 8629675

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

275 results

Search Page

Filters